(MedPage Today) — Donidalorsen (Dawnzera) received FDA approval for prophylactic treatment of hereditary angioedema (HAE) in adults and kids 12 years and older, Ionis Pharmaceuticals announced on Thursday.
The RNA-targeted therapy, a first for…
Source link : https://www.medpagetoday.com/allergyimmunology/allergy/117112
Author :
Publish date : 2025-08-21 21:19:00
Copyright for syndicated content belongs to the linked Source.
